Oric Pharmaceuticals, Inc.·4

Jan 6, 4:45 PM ET

Hoerter Steven L. 4

4 · Oric Pharmaceuticals, Inc. · Filed Jan 6, 2025

Insider Transaction Report

Form 4
Period: 2025-01-02
Transactions
  • Award

    Stock Option (right to buy)

    2025-01-02+35,00035,000 total
    Exercise: $8.26Exp: 2035-01-01Common Stock (35,000 underlying)
Footnotes (1)
  • [F1]1/12th of the shares subject to the option shall vest on each one month anniversary of January 2, 2025.

Documents

1 file
  • 4
    form4-01062025_090139.xmlPrimary